xiliarx
novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).
ipinzan 50 mg/1000 mg filmtabletten
zentiva k.s. - metformin hydrochlorid; vildagliptin -
ipinzan 50 mg/850 mg filmtabletten
zentiva k.s. - metformin hydrochlorid; vildagliptin -
vildagliptin holsten 50 mg tabletten
holsten pharma gmbh - geschäftsanschrift - (3001738) - tablette - 50 mg
melkart duo 50 mg/1000 mg-filmtabletten
g.l. pharma gmbh - metformin hydrochlorid; vildagliptin -
melkart duo 50 mg/850 mg-filmtabletten
g.l. pharma gmbh - metformin hydrochlorid; vildagliptin -
vildabetes 50 mg tablette
tad pharma gmbh (3044021) - vildagliptin - tablette - 50 mg - teil 1 - tablette; vildagliptin (30957) 50 milligramm
vildagliptin axunio 50 mg tabletten
axunio pharma gmbh (8130682) - tablette - 50 mg
vildagliptin spirig hc 50 mg tabletten
spirig healthcare ag - vildagliptinum - tabletten - vildagliptinum 50.000 mg, lactosum monohydricum 47.82 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 0.168 mg, magnesii stearas, pro compresso. - orales antidiabetikum - synthetika
vildagliptin nobel 50 mg tabletten
nobel pharma schweiz ag - vildagliptinum - tabletten - vildagliptinum 50 mg, lactosum 10 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 0.112 - 0.168 mg, magnesii stearas, pro compresso obducto. - diabetes mellitus typ 2 - synthetika